Open access
Sep 2026
ERK5 inhibition triggers CDK6 proteasomal degradation and enhances palbociclib efficacy in cancer cells
Claudia Faundez-Vidiella, Ylenia Sfragano, I. Tusa et al.
· bioRxiv · 0 citations